Cargando…

Hydroxychloroquine-related psychiatric disorders in COVID-19 patients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645021/ http://dx.doi.org/10.1007/s40278-020-85085-y

Ejemplares similares

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020)

Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis
por: Liao, Zheng-Ming, et al.
Publicado: (2022)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Drug interaction between hydroxychloroquine and metformin
Publicado: (2020)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Hydroxychloroquine in early pregnancy: risk of birth defects
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Hydroxychloroquine concentrations persist after drug discontinuation
Publicado: (2022)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021)

Hydroxychloroquine in IgA nephropathy: a systematic review
por: Stefan, Gabriel, et al.
Publicado: (2021)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

Improving Psychiatric Hospital Care for Pediatric Patients with Autism Spectrum Disorders and Intellectual Disabilities
por: Gabriels, Robin L., et al.
Publicado: (2012)

Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19
por: Casey, Jonathan D., et al.
Publicado: (2020)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

Irritable Bowel Syndrome and Psychiatric Disorders in Pakistan: A Case Control Study
por: Butt, Amna Subhan, et al.
Publicado: (2012)

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial
por: Brown, Samuel M., et al.
Publicado: (2020)

Systematic review: COVID-19 vaccine-related neurological disorders "exceedingly" rare
Publicado: (2022)

Affective Spectrum Disorders in an Urban Swedish Adult Psychiatric Unit: A Descriptive Study
por: Scharin, M., et al.
Publicado: (2012)

The Coexistence of Psychiatric Disorders and Intellectual Disability in Children Aged 3–18 Years in the Barwani District, India
por: Lakhan, Ram
Publicado: (2013)

Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
por: Magagnoli, Joseph, et al.
Publicado: (2020)

Anxiety disorders with Janssen's COVID-19 vaccine
Publicado: (2021)

Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020)

Is hydroxychloroquine beneficial for COVID-19 patients?
por: Li, Xing, et al.
Publicado: (2020)

Therapeutic status of hydroxychloroquine in COVID-19: A review
por: Kaur, Kirandeep, et al.
Publicado: (2020)

Microtubule-Associated Proteins in Mesial Temporal Lobe Epilepsy with and without Psychiatric Comorbidities and Their Relation with Granular Cell Layer Dispersion
por: Kandratavicius, Ludmyla, et al.
Publicado: (2013)

Rare reports of rheumatic disorder flares after COVID-19 vaccination
Publicado: (2022)

The utilization of hydroxychloroquine to reduce the main signs and symptoms of COVID-19 patients, a cross-sectional study
por: Alsuwaidan, Salem, et al.
Publicado: (2021)

Management of Psychiatric Disorders in Patients with Endocrine Disorders
por: Mishra, Kshirod Kumar, et al.
Publicado: (2022)

Heterogeneity in potential COVID-19 vaccine-related AEs
Publicado: (2021)

AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)

COVID-19 vaccination relatively safe in autoimmune diseases
Publicado: (2022)

Effects of Psychiatric Factors on Patient-Reported Outcomes after Surgical Correction of Lumbar Degenerative Kyphosis
por: Goh, Tae Sik, et al.
Publicado: (2018)

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Hydroxychloroquine‐induced erythema multiforme
por: Koumaki, Dimitra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3nand5icqs4djfcrr45a1rsfnb